Literature DB >> 18300125

Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.

Ishak Ozel Tekin1, Bekir Pocan, Ali Borazan, Edip Ucar, Guven Kuvandik, Sevil Ilikhan, Nejat Demircan, Cahit Ozer, Sinan Kadayifci.   

Abstract

We aimed to study the relationship between the C-reactive protein (CRP), albumin, and fibrinogen as cardiovascular risk factors in continuous ambulatory peritoneal dialysis (CAPD) patients, in the early stage of their therapy. The study included 21 CAPD patients as the study group (SG) and age- and sex-matched 21 healthy patients as the control group (CG). History and physical exam data were obtained for all cases, and demographic baseline characteristics were taken. Twelve-hour fasting serum levels of glucose, total cholesterol, HDL cholesterol, LDL cholesterol, triglyceride, total protein, albumin, hemoglobin, CRP, and fibrinogen were obtained. There was no statistically significant difference between the SG and CG in baseline characteristics, including age, sex, body mass index (BMI), smoking, and family history of cardiovascular disease. However, diabetes mellitus (DM) and hypertension (HTN) were significantly more common among the study group. The average total protein, albumin, and hemoglobin levels were significantly lower, and the CRP and fibrinogen levels were significantly higher (p < 0.001) in the SG. A positive correlation was seen (r = 0.443, p < 0.05) among CRP and fibrinogen levels in SG. There was no correlation among the other parameters in SG. For CG, there was no correlation seen for any studied parameters. When patients with and without cardiovascular disease (CVD) were compared, no correlation was seen between CRP and other parameters. A positive correlation of CRP and fibrinogen levels as cardiovascular risk factors was shown in early stage of CAPD patients. The CAPD patients with elevated levels of CRP and fibrinogen should receive close follow-up for cardiovascular disease prevention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18300125     DOI: 10.1080/08860220701813350

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  5 in total

1.  Cardiovascular disease markers in women with polycystic ovary syndrome with emphasis on asymmetric dimethylarginine and homocysteine.

Authors:  Ahmed M Mohamadin; Fawzia A Habib; Abdulrahman A Al-Saggaf
Journal:  Ann Saudi Med       Date:  2010 Jul-Aug       Impact factor: 1.526

Review 2.  Potential of Raman spectroscopy for the analysis of plasma/serum in the liquid state: recent advances.

Authors:  Drishya Rajan Parachalil; Jennifer McIntyre; Hugh J Byrne
Journal:  Anal Bioanal Chem       Date:  2020-01-03       Impact factor: 4.142

3.  Comparison of risk factors for cardiovascular disease in hemodialysis and peritoneal dialysis patients.

Authors:  Ozlem Harmankaya; Nilgul Akalin; Hatice Akay; Yildiz Okuturlar; Kayhan Erturk; Hakan Kaptanogullari; Hakan Kocoglu
Journal:  Clinics (Sao Paulo)       Date:  2015-09       Impact factor: 2.365

4.  Blood Group O Protect End-Stage Renal Disease Patients With Dialysis From Coronary Artery Disease.

Authors:  Zixiang Ye; Yaxin Wu; Yimin Tu; Mulei Chen; Yanxiang Gao; Linying Shi; Peizhao Li; Enmin Xie; Ziyu Guo; Qing Li; Xiaozhai Yu; Yike Li; Wenquan Niu; Jingyi Ren; Jingang Zheng
Journal:  Front Cardiovasc Med       Date:  2022-01-28

5.  Plasma fibrinogen and mortality in patients undergoing peritoneal dialysis: a prospective cohort study.

Authors:  Jing Yu; Tong Lin; Naya Huang; Xi Xia; Jianbo Li; Yagui Qiu; Xiao Yang; Haiping Mao; Fengxian Huang
Journal:  BMC Nephrol       Date:  2020-08-17       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.